MAKE WELL KNOWN.
LIVE

Serial Number

86036380

Owner

Inside Edge Consulting Group, Corp.

Attorney

Patricia Lawrence-Kolaras, Esq.

First Use Date

Aug 1, 2013

Filing Date

Aug 13, 2013

Add to watchlist:

No watchlists yet
View on USPTO

MAKE WELL KNOWN. Trademark

Serial Number: 86036380 • Registration: 4501468

MAKE WELL KNOWN. is a trademark filed by Inside Edge Consulting Group, Corp. on August 13, 2013. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Inside Edge Consulting Group, Corp. (7 trademarks)

103 College Road East, 2nd Floor
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

August 13, 2013

Registration Date

March 25, 2014

First Use Anywhere

August 1, 2013

First Use in Commerce

August 1, 2013

Published for Opposition

January 7, 2014

Goods & Services

Advertising and business management consultancy; Advertising and marketing consultancy; Advertising and promotion services and related consulting; Advertising consultation; Advertising relating to pharmaceutical products and in-vivo imaging products; Brand imagery consulting services; Branding services, namely, consulting, development, management and marketing of brands for businesses and/or individuals; Business advisory services, consultancy and information; Business and management consulting for healthcare providers and related businesses; Business assistance, advisory and consulting services in the field of pharmaceuticals; Business consultancy; Business consultation; Business consultation and management regarding marketing activities and launching of new products; Business consultation in the field of biotechnology; Business consultation services; Business consultation services in the fields of supply chain analysis, regulation compliance and counterfeit detection; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting in the consumer products industry; Business consulting services in the field of healthcare marketing; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management and consultation; Business management and consultation in the field of healthcare; Business management and consulting services for the health care industry, namely, providing industry expertise and supplier partnerships; Business management consultancy and advisory services; Business management consultancy as well as development of processes for the analysis and the implementation of strategy plans and management projects; Business management consultancy services; Business management consultation; Business management consulting; Business management consulting and advisory services; Business management consulting and advisory services for the pharmaceutical industry; Business management consulting, strategic planning and business advisory services provided to physicians; Business marketing consulting services; Business monitoring and consulting services, namely, tracking web sites and applications of others to provide strategy, insight, marketing, sales, operation, product design, particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumers, businesses, and market trends and actions; Business organisation and management consulting services; Business organization and management consulting; Business organization and operation consultancy; Business research consultation; Business services, namely, consumer research and consulting related thereto; Business services, namely, structuring, optimizing and change management consulting related to corporate in-house intellectual property departments and intellectual property asset management programs; Consultancy and advisory services in the field of business strategy; Consultancy services regarding business strategies; Consultation services in the field of company, business sector and industry data and research; Consultation services, namely, creative and strategic consultation regarding development and production of marketing campaigns for others; Consulting in the field of sales methods, sales management, and sales improvement; Consulting in the fields of healthcare operations management and hospital operations management; Consulting regarding intellectual property business risk mitigation processes; Consulting services in the cost and payment management of health care; Consulting services in the field of managing intellectual properties; Consulting services in the field of medical product approval for commercial purposes; Consulting services in the field of patient relationship management for healthcare providers; Consulting services, namely, to employers, community organizations, brokers and beneficiaries, related to consumer information regarding health care plan options, products and programs in the field of managed care and state and federal medical care programs; Consumer marketing research and consulting related thereto; Management consulting and advisory services in the areas of corporate growth strategy, innovation and growth processes, organizational transformation, and talent management and development strategies; Market research consultation; Market segmentation consultation; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Pharmaceutical cost management services and drug utilization review services; Professional business consultation; Professional business consulting; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing business management information in connection with consulting and advisory services in the field of strategic planning; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 9, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 9, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 9, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 9, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Sep 27, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 25, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 16, 2020 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Mar 16, 2020 8.OK
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 12, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
Apr 17, 2019 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 17, 2019 APRE
TEAS SECTION 8 RECEIVED
Apr 15, 2019 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 25, 2019 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 25, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2013 CNSA
ASSIGNED TO EXAMINER
Nov 29, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2013 NWOS
NEW APPLICATION ENTERED
Aug 16, 2013 NWAP